Long Term Antibiotic Therapy on Exacerbation frequency in Stable COPD
Research type
Research Study
Full title
A Phase III double-blind, randomised, placebo controlled trial of long term therapy on Exacerbation Rate in patients with stable COPD using Moxifloxacin, Azithromyin, or Doxycycline (delete as appropriate)
IRAS ID
108511
Contact name
Jadwiga Wedzicha
Contact email
Sponsor organisation
Imperial College Healthcare NHS Trust
Eudract number
2012-002199-15
ISRCTN Number
n/a
REC name
London - Hampstead Research Ethics Committee
REC reference
13/LO/0815
Date of REC Opinion
25 Jul 2013
REC opinion
Further Information Favourable Opinion